首页> 外文期刊>Anesthesiology >Propofol preferentially relaxes neurokinin receptor-2-induced airway smooth muscle contraction in guinea pig trachea.
【24h】

Propofol preferentially relaxes neurokinin receptor-2-induced airway smooth muscle contraction in guinea pig trachea.

机译:丙泊酚优先松弛豚鼠气管中神经激肽受体2诱导的气道平滑肌收缩。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Propofol is the anesthetic of choice for patients with reactive airway disease and is thought to reduce intubation- or irritant-induced bronchoconstriction by decreasing the cholinergic component of vagal nerve activation. However, additional neurotransmitters, including neurokinins, play a role in irritant-induced bronchoconstriction. We questioned the mechanistic assumption that the clinically recognized protective effect of propofol against irritant-induced bronchoconstriction during intubation was due to attenuation of airway cholinergic reflexes. METHODS: Muscle force was continuously recorded from isolated guinea pig tracheal rings in organ baths. Rings were subjected to exogenous contractile agonists (acetylcholine, histamine, endothelin-1, substance P, acetyl-substance P, and neurokinin A) or to electrical field stimulation (EFS) to differentiate cholinergic or nonadrenergic, noncholinergic nerve-mediated contraction with or without cumulatively increasing concentrations of propofol, thiopental, etomidate, or ketamine. RESULTS: Propofol did not attenuate the cholinergic component of EFS-induced contraction at clinically relevant concentrations. In contrast, propofol relaxed nonadrenergic, noncholinergic-mediated EFS contraction at concentrations within the clinical range (20-100 mum, n = 9; P < 0.05), and propofol was more potent against an exogenous selective neurokinin-2 receptor versus neurokinin-1 receptor agonist contraction (n = 6, P < 0.001). CONCLUSIONS: Propofol, at clinically relevant concentrations, relaxes airway smooth muscle contracted by nonadrenergic, noncholinergic-mediated EFS and exogenous neurokinins but not contractions elicited by the cholinergic component of EFS. These findings suggest that the mechanism of protective effects of propofol against irritant-induced bronchoconstriction involves attenuation of tachykinins released from nonadrenergic, noncholinergic nerves acting at neurokinin-2 receptors on airway smooth muscle.
机译:背景:异丙酚是反应性气道疾病患者的首选麻醉药,据认为可通过减少迷走神经激活的胆碱能成分来减少插管或刺激性支气管收缩。但是,其他神经递质(包括神经激肽)在刺激物引起的支气管收缩中起作用。我们质疑机理假设,即在插管过程中异丙酚对刺激性支气管收缩的临床公认保护作用是由于气道胆碱能反射减弱。方法:连续记录分离的豚鼠气管环在器官浴中的肌肉力量。对环进行外源性收缩激动剂(乙酰胆碱,组胺,内皮素-1,物质P,乙酰基物质P和神经激肽A)或电场刺激(EFS),以区分胆碱能或非肾上腺素能,非胆碱能神经介导的有或无神经收缩累积增加的异丙酚,硫喷妥钠,依托咪酯或氯胺酮的浓度。结果:在临床相关浓度下,异丙酚未减弱EFS引起的收缩的胆碱能成分。相比之下,丙泊酚在临床范围内的浓度(20-100微米,n = 9; P <0.05)下可放松非肾上腺素能,非胆碱能介导的EFS收缩,并且丙泊酚对外源性选择性神经激肽2受体比神经激肽1更有效受体激动剂收缩(n = 6,P <0.001)。结论:在临床相关浓度下,异丙酚可使非肾上腺素能,非胆碱能介导的EFS和外源性神经激肽收缩的气道平滑肌松弛,但不能由EFS的胆碱能成分引起的收缩。这些发现表明,丙泊酚对刺激性支气管收缩的保护作用机制涉及减弱从作用于气道平滑肌上神经激肽2受体的非肾上腺素能,非胆碱能神经释放的速激肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号